VORASIDENIB

Brand name:

• Voranigo®

Pharmaceutical company:

SERVIER LABORATORIES (AUST.) PTY. LTD.

Condition/indication:
(therapeutic use)

• Astrocytoma or oligodendroglioma

PBAC Submission type:

New PBS listing (–)

Comment:

--

Public Summary Document:

Not yet available

Related medicines:

--

Submission received for:

July 2025 PBAC meeting

Opportunity for consumer comment:

Open 02/04/2025 and close 28/05/2025 (see PBS Website)

PBAC meeting:

Held on 09/07/2025

PBAC outcome published:

Not Recommended (see PBAC Outcomes)

Lodgement of required documentation:

Not applicable

Agreement to listing arrangements:

Not applicable

Government processes:

Not applicable

Medicine listed on the PBS:

Not applicable

---